Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × HMPL-013 × Gastrointestinal × Clear all

Status

Unknown 35 Recruiting 29 Not yet recruiting 15 Completed 8 Active not recruiting 5 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

regorafenib 2 peginterferon alfa-2a 1 pegilodecakin 1 onvansertib 1 omburtamab I-131 1 guselkumab 1 derazantinib 1 avapritinib 1 Tenofovir 1 Melphalan 1 IMM-101 1 IFL protocol 1 HMPL-013 1 Everolimus 1 Brachytherapy 1 Bevacizumab 1 AM0010 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195514 2026-01-30

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Takeda

No longer available

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡